NEW YORK (Daily Pakistan Online) - American biotechnology company Moderna has announced that the results of the first trial phase of its Code 19 vaccine have been successful, making the vaccine safer for patients and helping to boost immunity. ۔ According to a study published in the New England Medical Journal, people who took two doses of the modern vaccine were found to be many times more likely to recover from virus-killing antibodies to code 19 than those who did not. None of the vaccines had any serious side effects, although some people complained of fatigue, headaches, chills, and muscle aches. However, these effects were seen in those who took large doses of other foods.
It should be noted that Moderna is the first company to start the trial of the vaccine on humans on March 16 and now after 66 days its positive results have also started coming to light.
